BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30014520)

  • 21. H19/TET1 axis promotes TGF-β signaling linked to endothelial-to-mesenchymal transition.
    Cao T; Jiang Y; Li D; Sun X; Zhang Y; Qin L; Tellides G; Taylor HS; Huang Y
    FASEB J; 2020 Jun; 34(6):8625-8640. PubMed ID: 32374060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.
    Song Y; Liu C; Liu X; Trottier J; Beaudoin M; Zhang L; Pope C; Peng G; Barbier O; Zhong X; Li L; Wang L
    Hepatology; 2017 Oct; 66(4):1183-1196. PubMed ID: 28407375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2.
    Zhu X; Zhang T; Zhang Y; Chen H; Shen J; Jin X; Wei J; Zhang E; Xiao M; Fan Y; Mao R; Zhou G
    Cell Signal; 2020 Feb; 66():109470. PubMed ID: 31730895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.
    Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
    Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
    Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
    Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
    Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
    Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymosin β4 suppresses CCl
    Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
    J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
    Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
    Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
    Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
    Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
    Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
    J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop.
    Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H
    Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
    Braun L; Gruppuso P; Mikumo R; Fausto N
    Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis.
    Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
    Biochem Biophys Res Commun; 2018 Nov; 506(1):189-193. PubMed ID: 30342849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.